# The Procter & Gamble Company – FDA Inspection, Jun 20, 2024

Source: https://www.keypedia.com/records/fda_inspections/the-procter-gamble-company/debff6bf-93a5-4fb3-9b0e-1a1940271a46
Source feed: FDA_Inspections

> FDA inspection 1233912 of The Procter & Gamble Company, June 20, 2024. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1233912
- Company Name: The Procter & Gamble Company
- Inspection Date: 2024-06-20
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Postmarket Assurance: Devices
- Product Type: Devices
- Center: Medical Devices & Rad Health
- Office Name: Center for Devices and Radiological Health
- Citation Count: 0

## Related Documents

- [FDA Inspection 1178155 - 2022-08-23](https://www.keypedia.com/records/fda_inspections/the-procter-gamble-company/4fb2434e-5cdd-4722-b416-d320b83e1e1e)
- FDA Inspection 1012418 - 2017-05-10
- FDA Inspection 696660 - 2010-11-05

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/amber-m-capello-jones/d34f92a0-d580-4028-9d31-c6cd7c13ce0f)

Company: https://www.keypedia.com/companies/the-procter-gamble-company/3840d9aa-6522-4958-9807-1bf58d006c44

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7